Nucleotide sequence analysis of the sialyltransferase genes of meningococcal serogroups B, C, Y and W135

Journal of Molecular Microbiology and Biotechnology

Volumn 5, Issue 2, 2003, Pages 82-86

  Lewis, C ^a   Diggle, M A ^a   Clarke, S C ^a,b  

^a STOBHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Meningococci; Neisseria meningitidis; Serogrouping; SiaD

Indexed keywords

AGAROSE; BACTERIAL DNA; MENINGOCOCCUS VACCINE; NUCLEOTIDE; SIALYLTRANSFERASE; PRIMER DNA;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL PROTOCOL; GENE AMPLIFICATION; LABORATORY; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLING; SEQUENCE ANALYSIS; UNITED KINGDOM; BACTERIUM IDENTIFICATION; CLASSIFICATION; DNA SEQUENCE; ENZYMOLOGY; EPIDEMIC MENINGITIS; EVALUATION; GENETICS; HUMAN; METHODOLOGY; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY; SEROTYPING;

NEISSERIA; NEISSERIA MENINGITIDIS;

BACTERIAL TYPING TECHNIQUES; DNA PRIMERS; HUMANS; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SEROTYPING; SIALYLTRANSFERASES;

EID: 0041695831     PISSN: 14641801     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069978     Document Type: Article

References (29)

1. Borrow, R., Claus, H., Chaudhry, U., Guiver, M., Kaczmarski, E.B., Frosch, M., Fox, A.J. 1998. siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett 159:209-214.
2. Borrow, R., Claus, H., Guiver, M., Smart, L., Jones, D.M., Kaczmarski, E.B., Frosch, M., Fox, A.J. 1997. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect 118:111-117.
3. Brooks, J.L., Fallon, R.J., Heckels, J.E. 1995. Sequence variation in class 1 outer membrane protein in Neisseria meningitidisisolated from patients with meningococcal infection and close household contacts. FEMS Microbiol Lett 128:145-150.
4. Clarke, S.C., Brownlie, S., Denham, B.C., Reid, J.A., Thom, L., Christie, P., Edwards, G.F. 2001a. Meningococcal disease in Scotland 1999. SCIEH Weekly Rep 35:130-133.
5. Clarke, S.C., Diggle, M.A. 2002. Automated PCR/sequence template purification. Mol Biotechnol 21:221-224.
6. Clarke, S.C., Diggle, M.A., Edwards, G.F. 2001b. Semiautomation of multilocus sequence typing for the characterisation of clinical isolates of Neisseria meningitidis. J Clin Microbiol 39: 3066-3071.
7. Clarke, S.C., Diggle, M.A., Edwards, G.F. 2001c. Automated non-culture-based sequence typing of meningococci from body fluids. Br J Biomed Sci 58:230-234.
8. Clarke, S.C., Diggle, M.A., Reid, J.A., Thom, L., Edwards, G.F. 2001d. Introduction of an automated service for the laboratory confirmation of meningococcal disease in Scotland. J Clin Pathol 54:556-557.
9. Clarke, S.C., Edwards, G.F. 2000. Implications for the serogroup incidence of meningococcal disease after the introduction of the MenC vaccine. Scott Med J 45:67.
10. Clarke, S.C., Reid, J., Thom, L., Denham, B.C., Edwards, G.F. 2001e. Meningococcal disease due to serogroup Y in Scotland, 1992-1999. Br J Biomed Sci 58:17-19.
11. Clarke, S.C., Reid, J., Thom, L., Denham, B.C., Edwards, G.F. 2002. Laboratory confirmation of meningococcal disease in Scotland, 1993-1999. J Clin Pathol 55:32-36.
12. Chief Medical Officer 1999a. Introduction of immunisation against group C meningococcal infection. Scottish Executive Health Department, Scotland, PAL51979.
13. Chief Medical Officer 1999b. Start of the new meningococcal C conjugate vaccine immunisation programme. Department of Health, England and Wales. PL/CMO/99/4.
14. Diggle, M.A., Edwards, G.F., Clarke, S.C. 2001. Automation of fluorescence-based PCR for confirmation of meningococcal disease. J Clin Microbiol 39:4518-4519.
15. Feavers, I.M., Fox, A.J., Gray, S., Jones, D.M., Maiden, M.C. 1996. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 3: 444-450.
16. Feavers, I.M., Gray, S.J., Urwin, R., Russell, J.E., Bygraves, J.A., Kaczmarski, E.B., Maiden, M.C. 1999. Multilocus sequence typing and antigen gene sequencing in the investigation of a meningococcal disease outbreak. J Clin Microbiol 37:3883-3887.
17. Feavers, I.M., Suker, J., McKenna, A.J., Heath, A.B., Maiden, M.C. 1992. Molecular analysis of the serotyping antigens of Neisseria meningitidis. Infect Immun 60:3620-3629.
18. Guiver, M., Borrow, R., Marsh, J., Gray, S.J., Kaczmarski, E.B., Howells, D., Boseley, P., Fox, A.J. 2000. Evaluation of the applied biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 28:173-179.
19. Jelfs, J., Munro R., Wedege, E., Caugant, D.A. 2000. Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread. Clin Diagn Lab Immunol 7:390-395.
20. Maiden, M.C., Bygraves, J.A., McCarvil, J., Feavers, I.M. 1992. Identification of meningococcal serosubtypes by polymerase chain reaction. J Clin Microbiol 30:2835-2841.
21. Maiden, M.C., Spratt, B.G. 1999. Meningococcal conjugate vaccines: New opportunities and new challenges. Lancet 354:615-616.
22. Maiden, M.C., Stuart, J.M. 2002. Carriage of sero-group C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359:1829-1831.
23. Molling, P., Unemo, M., Backman, A., Olcen, P. 2000. Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. APMIS 108:509-516.
24. Newcombe, J., Cartwright, K., Palmer, W.H., McFadden, J. 1996. PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol 34:1637-1640.
25. Popovic, T., Sacchi, C.T., Reeves, M.W., Whitney, A.M., Mayer, L.W., Noble, C.A., Ajello, G.W., Mostashari, F., Bendana, N., Lingappa, J., Hajjeh, R., Rosenstein, N.E. 2000.Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis 6: 428-429.
26. Porritt, R.J., Mercer, J.L., Munro, R. 2000. Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction (PCR). Pathology 32:42-45.
27. Rosenstein, N.E., Perkins, B.A., Stephens, D.S., Lefkowitz, L., Cartter, M.L., Danila, R., Cieslak, P., Shutt, K.A., Popovic, T., Schuchat, A., Harrison, L.H., Reingold, A.L. 1999. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 180:1894-1901.
28. Suker, J., Feavers, I.M., Achtman, M., Morelli, G., Wang, J.F., Maiden, M.C. 1994. The porA gene in serogroup A meningococci: Evolutionary stability and mechanism of genetic variation. Mol Microbiol 12:253-265.
29. Taha, M.K., Achtman, M., Alonso, J.M., Greenwood, B., Ramsay, M., Fox, A., Gray, S., Kaczmarski, E. 2000. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356:2159.